International Newborn Screening: Where Are We in Saudi Arabia?

被引:0
作者
Alhusseini, Noara [1 ]
Almuhanna, Yara [1 ]
Alabduljabbar, Lama [1 ]
Alamri, Soaad [1 ]
Altayeb, Maryam [1 ]
Askar, Ghadi [1 ]
Alsaadoun, Noor [1 ]
Ateq, Khadijah [3 ]
Aleissa, Mariam M. [1 ,2 ]
机构
[1] Alfaisal Univ, Med Sch, Riyadh, Saudi Arabia
[2] Publ Hlth Author, Publ Hlth Lab, Riyadh, Saudi Arabia
[3] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
关键词
Newborn screening program; Prevention; Early intervention; Noncommunicable diseases; Saudi Arabia; TANDEM MASS-SPECTROMETRY; ECONOMIC-EVALUATION;
D O I
10.1007/s44197-024-00263-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Newborn screening (NBS) programs are believed to play an important role in the decrease of infant mortality rates in many countries. This is achieved through offering early detection and treatment of many genetic as well as metabolic disorders prior to the onset of symptoms. Our paper examines NBS across seven diverse nations: Saudi Arabia, the United States, Japan, Singapore, Canada, Australia, and the United Kingdom. This paper discusses the diseases screened for by each country, latest additions, as well as future recommendations, when applicable. Employing a comparative approach, we conducted a comprehensive review of the most recent published literature on NBS programs in each country and subsequently examined their latest implemented NBS guidelines as outlined on their respective official government health sector websites. We then reviewed the economic feasibility of each of these programs and factors that affect implementation and overall benefit. While all six countries employ well-developed programs, variations are observed. Those variations are mainly attributed to disparities in access, resource scarcity, financial availability, as well as ethical and cultural considerations. From a local perspective, we recommend conducting further population-based studies to assess the epidemiological data in relation to the disease burden on the country's economy. Moreover, we recommend updating national and international guidelines to contain a more comprehensive approach on policies, operation, and sustainability to deliver a service through the lens of value-based healthcare.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 35 条
  • [1] [Anonymous], 2022, INT J NEONATAL SCREE
  • [2] [Anonymous], NEWBORN BABIES MOH I
  • [3] Australian Government Department of Health and Aged Care, WHAT IS SCREENED PRO
  • [4] Newborn Screening: From Guthrie to Whole Genome Sequencing
    Caggana, Michele
    Jones, Elizabeth A.
    Shahied, S. I.
    Tanksley, Susan
    Hermerath, Cheryl A.
    Lubin, Ira M.
    [J]. PUBLIC HEALTH REPORTS, 2013, 128 : 14 - 19
  • [5] Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth
    Chan, Su-Wan Bianca
    Zhong, Youjia
    Lim, Soon Chuan James
    Poh, Sherry
    Teh, Kai Liang
    Soh, Jian Yi
    Chong, Chia Yin
    Thoon, Koh Cheng
    Seng, Michaela
    Tan, Ee Shien
    Arkachaisri, Thaschawee
    Liew, Woei Kang
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [6] CHEO NSO, DIS INFORM CHEO NSO
  • [7] The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: Results from a decision-analytic model
    Cipriano, Lauren E.
    Rupar, C. Anthony
    Zaric, Gregory S.
    [J]. VALUE IN HEALTH, 2007, 10 (02) : 83 - 97
  • [8] Committee UNS, 2023, SIMPLE SCREENING COM
  • [9] Economic evaluation of tandem mass spectrometry screening in California
    Feuchtbaum, L
    Cunningham, G
    [J]. PEDIATRICS, 2006, 117 (05) : S280 - S286
  • [10] The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience
    Grosse, Scott D.
    Thompson, John D.
    Ding, Yao
    Glass, Michael
    [J]. MILBANK QUARTERLY, 2016, 94 (02) : 366 - 391